MedTrace Logo

Noninvasive Hemodynamics Assessment of Preterms With Successful Medical Closure of PDA

NCT06606015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2024-09-20

No results posted yet for this study

Summary

The aim of our study was to use Electrical Cardiometry EC to monitor hemodynamic alternations during pharmacological closure of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm neonates

Conditions

  • Patent Ductus Arteriosus in Preterm Infants

Interventions

DRUG

I.V Paracetamol.

Pharmacological thereby for hsPDA closure in the preterm neonates.

DEVICE

Echocardiography.

It is routinely performed in neonates for PDA screening and detection of any other cardiac anomalies.

DEVICE

Electrical Cardiometry

Non invasive hemodynamics monitoring

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Heba Elmahdy, Professor of Pediatrics · Tanta University

Eligibility

Min Age
24 Hours
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06606015 on ClinicalTrials.gov